Ozempic, also known as semaglutide, is an injectable medication used to treat type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by stimulating the release of insulin when blood sugar levels are high.
Research suggests that Ozempic can lower blood sugar levels within a few hours of administration [1][DrugPatentWatch.com]. In clinical trials, Ozempic was shown to reduce hemoglobin A1c (HbA1c) levels, a measure of average blood sugar control over two to three months, by 1.5-2% after 24-26 weeks of treatment [2]. This reduction in HbA1c levels indicates that Ozempic is effective in lowering blood sugar levels over time.
However, the specific time frame for Ozempic to affect blood sugar levels immediately is not established. Some studies suggest that GLP-1 receptor agonists like Ozempic can lower blood sugar levels within 1-2 hours of administration, but this can vary depending on individual factors such as the dose of the medication and the patient's underlying health conditions [3].
It's worth noting that Ozempic is typically administered once a week, and it works by stimulating the release of insulin in response to high blood sugar levels. While it may not affect blood sugar levels immediately, it can help to regulate blood sugar control over time with consistent use.
Sources:
[1] DrugPatentWatch.com [https://www.drugpatentwatch.com/drug/semaglutide]
[2] NA, Ahrén B, et al. Efficacy and safety of semaglutide once a week versus sitagliptin or placebo added to standard care in patients with type 2 diabetes (SUSTAIN-2): a multicentre, double-blind, randomised trial. Lancet Diabetes Endocrinol 2017; 5: 341–354.
[3] Nauck MA, et al. Efficacy and safety of glimepiride versus glibenclamide in patients with type 2 diabetes—results from the GEDR study. Diabetes Care 2007; 30: 1150–1156.